相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation
Per Ljungman et al.
CLINICAL INFECTIOUS DISEASES (2020)
Letermovir for Secondary Prophylaxis of Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Cell Transplantation: Results from the French Compassionate Program
Christine Robin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Viral reactivations following hematopoietic stem cell transplantation in pediatric patients - A single center 11-year analysis
Franziska Duever et al.
PLOS ONE (2020)
Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials
Roy F. Chemaly et al.
CLINICAL INFECTIOUS DISEASES (2019)
Factors associated with cytomegalovirus infection in children undergoing allogeneic hematopoietic stem-cell transplantation
Tang-Her Jaing et al.
MEDICINE (2019)
The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT
Martin Schmidt-Hieber et al.
ANNALS OF HEMATOLOGY (2019)
Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)
Per Ljungman et al.
LANCET INFECTIOUS DISEASES (2019)
Haploidentical allogeneic hematopoietic stem cell transplantation increases the risk of cytomegalovirus infection in adult patients with acute leukemia
Cheng-Hsien Lin et al.
TRANSPLANT INFECTIOUS DISEASE (2019)
Age-dependent determinants of infectious complications profile in children and adults after hematopoietic cell transplantation: lesson from the nationwide study
Krzysztof Czyzewski et al.
ANNALS OF HEMATOLOGY (2019)
Recommendations and guidelines for the treatment of pneumonia in Taiwan
Chih-Chen Chou et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2019)
Who Is the Patient at Risk of CMV Recurrence: A Review of the Current Scientific Evidence with a Focus on Hematopoietic Cell Transplantation
Jan Styczynski
INFECTIOUS DISEASES AND THERAPY (2018)
Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials
Per Ljungman et al.
CLINICAL INFECTIOUS DISEASES (2017)
Evaluation of COBAS AmpliPrep/COBAS TaqMan CMV Test for use in hematopoietic stem cell transplant recipients
Poornima Ramanan et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2017)
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
F. M. Marty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cytomegalovirus Infection and Treatment in Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study from a Single Institution in an Endemic Area
Hsin-Chen Lin et al.
TURKISH JOURNAL OF HEMATOLOGY (2017)
A collaborative study to establish the 1st WHO International Standard for human cytomegalovirus for nucleic acid amplification technology
Jacqueline F. Fryer et al.
BIOLOGICALS (2016)
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
Pierre Teira et al.
BLOOD (2016)
Half-dose ganciclovir preemptive treatment of cytomegalovirus infection after pediatric allogeneic hematopoietic stem cell transplantation
H. Y. Ju et al.
TRANSPLANT INFECTIOUS DISEASE (2016)
Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study
Margaret L. Green et al.
LANCET HAEMATOLOGY (2016)
Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group
Katsuto Takenaka et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Cytomegalovirus load at treatment initiation is predictive of time to resolution of viremia and duration of therapy in hematopoietic cell transplant recipients
Susanna K. Tan et al.
JOURNAL OF CLINICAL VIROLOGY (2015)
Relationship between cytomegalovirus (CMV) reactivation, CMV-driven immunity, overall immune recovery and graft-versus-leukaemia effect in children
Mohamed Jeljeli et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study
Susanne Stoelben et al.
TRANSPLANT INTERNATIONAL (2014)
CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia
Margaret L. Green et al.
BLOOD (2013)
Management of cytomegalovirus infection in haemopoietic stem cell transplantation
Vincent Emery et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation: experience in a center with a high seroprevalence of both CMV and hepatitis B virus
Yi-Chang Liu et al.
ANNALS OF HEMATOLOGY (2012)
Efficacy of a Viral Load-Based, Risk-Adapted, Preemptive Treatment Strategy for Prevention of Cytomegalovirus Disease after Hematopoietic Cell Transplantation
Margaret L. Green et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients
Filippo Milano et al.
BLOOD (2011)
Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
Per Ljungman et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2011)
Immunological Monitoring for Guidance of Preemptive Antiviral Therapy for Active Cytomegalovirus Infection in Allogeneic Stem-Cell Transplant Recipients: A Pilot Experience
Carlos Solano et al.
TRANSPLANTATION (2011)
Interlaboratory Comparison of Cytomegalovirus Viral Load Assays
X. L. Pang et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Relationship between pp65 antigenemia levels and real-time quantitative DNA PCR for Human Cytomegalovirus (HCMV) management in immunocompromised patients
Elisabetta Cariani et al.
BMC INFECTIOUS DISEASES (2007)
Seroprevalence of cytomegalovirus infection in the United States, 1988-1994
Stephanie A. S. Staras et al.
CLINICAL INFECTIOUS DISEASES (2006)
Oral valganciclovir as pre-emptive therapy has similar efficacy on cytomegalovirus DNA load reduction as intravenous ganciclovir in allogeneic stem cell transplantation recipients
PLJ van der Heiden et al.
BONE MARROW TRANSPLANTATION (2006)
Recurrent cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation in Taiwan: A single institutional experience
SJ Wu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients
FM Mattes et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation
P Reusser et al.
BLOOD (2002)
Successful preemptive cidofovir treatment for CMV antigenemia after dose-reduced conditioning and allogeneic blood stem cell transplantation
U Platzbecker et al.
TRANSPLANTATION (2001)
Rising pp65 antigenemia during preemptive anticytomegalovinus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes
WG Nichols et al.
BLOOD (2001)
分享论文
